RedHill Biopharma (RDHL) Other Non-Current Liabilities (2011 - 2025)
RedHill Biopharma's (RDHL) quarterly Other Non-Current Liabilities came in at $456000.0 in Q4 2025, down 56.86% on a QoQ basis from $1.1 million in Q4 2016.
RedHill Biopharma (RDHL) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has 7 years of Other Non-Current Liabilities data on file, last reported at $456000.0 in Q4 2025.
- On a quarterly basis, Other Non-Current Liabilities changed N/A year-over-year to $456000.0 in Q4 2025; TTM through Dec 2025 was $456000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $456000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q4 2025 stood at $456000.0, down from $1.1 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for RDHL reached as high as $456000.0 in Q4 2025 and fell as low as $456000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 456,000.00 |
| Dec 31, 2016 | 1.06 Mn |
| Sep 30, 2016 | 1.06 Mn |
| Jun 30, 2016 | 1.06 Mn |
| Mar 31, 2016 | 1.06 Mn |
| Dec 31, 2015 | 1.06 Mn |
| Sep 30, 2015 | 1.06 Mn |
| Jun 30, 2015 | 1.06 Mn |
| Mar 31, 2015 | 1.06 Mn |
| Dec 31, 2014 | 1.53 Mn |
| Sep 30, 2014 | 1.53 Mn |
| Jun 30, 2014 | 1.53 Mn |
| Mar 31, 2014 | 1.59 Mn |
| Dec 31, 2013 | 1.87 Mn |
| Sep 30, 2013 | 2.50 Mn |
| Jun 30, 2013 | 3.23 Mn |
| Mar 31, 2013 | 3.26 Mn |
| Dec 31, 2012 | 3.27 Mn |
| Dec 31, 2011 | 2.69 Mn |